BioPharma Dive3d
Certis Oncology Announces Issuance of U.S. Patent for its Proprietary CertisAI Predictive Oncology Intelligence Platform™
San Diego, CA — February 12, 2025 — Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has ...
Healio8d
Vistagen receives US patent for nonopioid neuropathic pain therapy
The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced ...
Business Wire16d
RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office
The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for Adhesion to Surfaces,” which co ...